EP3390452

LABORATOIRE FRANÇAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Application Number
EP16826758A
Filing Date
Dec 16, 2016
Status
Revoked
May 5, 2023
Grant Date
May 26, 2021
External Links
Slate, Register

Biblio Summary

The patent EP3390452B1 was granted on May 26, 2021 by Laboratoire Français Du Fractionnement Et Des Biotechnologies The patent is currently Revoked.

The table below shows 1 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMAN LIMITEDFeb 28, 2022ADMISSIBLE

The table below shows the patents of Laboratoire Français Du Fractionnement Et Des Biotechnologies that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3481415Stable Liquid FibrinogenSep 6, 20233
EP3806891Combination Of Factor Vii And An Anti-Factor Ix/X Bispecific AntibodyAug 2, 20231
EP2651978Use Of An Antibody Directed Against A Membrane ProteinJan 12, 20221